EE293 A Cost Analysis on Renal Disease Progression of Fabry Disease Patients Treated with Agalsidase Beta Based on Renal Disease Stage in Colombia
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.594
https://www.valueinhealthjournal.com/article/S1098-3015(23)00694-0/fulltext
Title :
EE293 A Cost Analysis on Renal Disease Progression of Fabry Disease Patients Treated with Agalsidase Beta Based on Renal Disease Stage in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00694-0&doi=10.1016/j.jval.2023.03.594
First page :
Section Title :
Open access? :
No
Section Order :
10076